IL1B and acute myeloid leukemia: Several studies have reported elevated levels of both IL-1β and IL-1 receptors in patients with AML, whereas levels of IL-1 receptor antagonist (IL-1RA) were decreased both in peripheral blood and in bone marrow [12].